PATENT CLAIM ANALYSIS

Application Number: 15879806
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "465000"]

Abstract:
Disclosed herein are pharmaceutically acceptable rapid dissolve vaginal tablet compositions comprising one or more active pharmaceutical ingredients suitable for therapy via topical action or systemic absorption, and methods of making and using such compositions.

Claim (Index 19):
The method of  claim 17  or  18 , further comprising:\n a) preparing rapid dissolve microgranules comprising tenofovir, mannitol, low-substituted hydroxyethylcellulose, and optionally crospovidone and bioadhesive chitosan; \n b) granulating mannitol and crosspoividone each having an average particle size of not more than about 30 \u03bcm to produce rapidly dispersing microgranules; \n c) blending the rapid dissolve microgranules from step a), rapidly dispersing microgranules from step b), and microcrystalline cellulose, crospovidone, and sodium stearyl fumarate to form a blend; and \n d) compressing the blend of step c) into rapid dissolve tablets using a rotary tablet press; \n wherein each rapid dissolve tablet disintegrates in about 60 seconds when tested by USP method <701> disintegration time.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 86.0
- Lexical Diversity: 1.09091
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14917125', '15387317', '14743026', '13974725', '10827106']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6926063717815113
- 35 USC 102 Novelty (BERT): 0.509901184858008
- Combined Prediction Score: 0.674335853089161
- Mean Citation Score: 252.85325200000003
- Max Citation Score: 272.79074
- Similarity Product: 203.8759418152524

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test